ARTICLE | Company News
Merz sales and marketing update
November 14, 2011 8:00 AM UTC
Merz launched Xeomin incobotulinumtoxinA in the U.S. as a temporary improvement in the appearance of moderate to severe glabellar lines (frown lines between the eyebrows). Merz already markets Xeomin...